ARCHIVES

Study Finds Trial Results Reliable At Three Years

This article is from The Cancer Letter archive.

Vol. 28 No. 7 | July 29, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Official Says He Hopes to “Put More Money” Into SPOREs.

April 14, 2006

NCI Shifts Money to Save 100 Training Slots

July 14, 1989

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

January 27, 2012

In Legal Brawl, UPenn and Abramson Institute Allege Former Director Craig Thompson “Absconded” With Inventions

March 9, 2012

House Committee on Appropriations approves $28.5 billion for NIH.

June 24, 2005

Retraction Based On Data Given To Duke Last November, But Apparently Disregarded

October 29, 2010